542934.BO Stock Analysis
54
Avoid
Based on Eyestock quantitative analysis, 542934.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical critical care & health care products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. The company is also engaged in the business of marketing pharmaceutical critical care & health care products. The company offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. The company has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. The company is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.